Grufity logo
Grufity logo

Latest SABBY MANAGEMENT, LLC Stock Portfolio

$110Million | No. of Holdings #16

SABBY MANAGEMENT, LLC Performance

2026 Q2+1.64%
YTD-88.32%
2025-9.57%

About SABBY MANAGEMENT, LLC and 13F Hedge Fund Stock Holdings

On 2026-08-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, SABBY MANAGEMENT, LLC reported an equity portfolio of $110.5 Millions as of 30 Jun, 2026. <br><br> The top stock holdings of SABBY MANAGEMENT, LLC are SPY, , FAMI. The fund has invested 3.7% of it's portfolio in STATE STREET SPDR S&P and 3.2% of portfolio in TOYO CO LTD. <br><br> The fund managers got completely rid off ALPHATON CAPITAL CORP (PRTG), BIG TREE CLOUD HLDGS LTD and TOKEN CAT LTD (TC) stocks. They significantly reduced their stock positions in INMED PHARMACEUTICALS (INM), BRIACELL THERAPEUTICS CORP (BCTX) and SENESTECH INC (SNES). SABBY MANAGEMENT, LLC opened new stock positions in TOYO CO LTD, FARMMI INC (FAMI) and BIOAFFINITY TECHNOLOGIES (BIAF). The fund showed a lot of confidence in some stocks as they added substantially to TEMPEST THERAPEUTICS INC (TPST), REVELATION BIOSCIENCES INC (REVB) and STATE STREET SPDR S&P (SPY).
SABBY MANAGEMENT, LLC Equity Portfolio Value
Last Reported on: 14 Aug, 2026
$110Million
  as of Aug 14, 2026

SABBY MANAGEMENT, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that SABBY MANAGEMENT, LLC made a return of 1.64% in the last quarter. In trailing 12 months, it's portfolio return was -82.19%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
toyo co ltd3,501,730
farmmi inc840,307
cervomed inc771,528
paranovus entertnmnt tech lt560,519
bioaffinity technologies296,905
smart power corp263,214
sidus space inc121,889
nuwellis inc49,935
New stocks bought by SABBY MANAGEMENT, LLC

Additions

Ticker% Inc.
tempest therapeutics inc2,763
revelation biosciences inc111
state street spdr s&p101
briacell therapeutics corp9.21
Additions to existing portfolio by SABBY MANAGEMENT, LLC

Reductions

Ticker% Reduced
inmed pharmaceuticals-79.58
briacell therapeutics corp-49.99
briacell therapeutics corp-41.57
senestech inc-35.13
SABBY MANAGEMENT, LLC reduced stake in above stock

Sold off

Ticker$ Sold
alphaton capital corp-654,785
pop culture group co ltd-201,129
calidi biotherapeutics inc-103,855
biodexa pharmaceuticals plc-159,092
big tree cloud hldgs ltd-337,147
arcadia biosciences inc-158,085
lyra therapeutics inc-51,103
trx gold corp-150,000
SABBY MANAGEMENT, LLC got rid off the above stocks

Sector Distribution

SABBY MANAGEMENT, LLC has about 81.4% of it's holdings in Others sector.

  • Others
  • Healthcare
  • Utilities
  • Basic Materials
Sector%
Others81.4
Healthcare13.7
Utilities2.2
Basic Materials1.8

Market Cap. Distribution

SABBY MANAGEMENT, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

  • UNALLOCATED
  • NANO-CAP
Category%
UNALLOCATED81.4
NANO-CAP17.6

Stocks belong to which Index?

About 0% of the stocks held by SABBY MANAGEMENT, LLC either belong to S&P 500 or RUSSELL 2000 index.

  • Others
Index%
Others100
Top 5 Winners (%)%
INM
inmed pharmaceuticals
84.5 %
SPY
state street spdr s&p
10.7 %
Top 5 Winners ($)$
SPY
state street spdr s&p
0.4 M
INM
inmed pharmaceuticals
0.1 M
Top 5 Losers (%)%
BCTX
briacell therapeutics corp
-25.5 %
BCTX
briacell therapeutics corp
-21.9 %
TPST
tempest therapeutics inc
-19.8 %
REVB
revelation biosciences inc
-10.8 %
BCTX
briacell therapeutics corp
-10.2 %
Top 5 Losers ($)$
TPST
tempest therapeutics inc
-0.1 M
BCTX
briacell therapeutics corp
-0.1 M
BCTX
briacell therapeutics corp
0.0 M
SNES
senestech inc
0.0 M
REVB
revelation biosciences inc
0.0 M

SABBY MANAGEMENT, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of SABBY MANAGEMENT, LLC

SABBY MANAGEMENT, LLC has 16 stocks in it's portfolio. About 10.3% of the portfolio is in top 10 stocks. TPST proved to be the most loss making stock for the portfolio. SPY was the most profitable stock for SABBY MANAGEMENT, LLC last quarter.

$12.02MTotal Value
30.00Positions
14 Aug, 2026Last Reported
Current holdings of Current Stock Holdings of SABBY MANAGEMENT, LLC, last reported on 14 Aug, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
CANF
Can Fite Biofarma Ltd

Can Fite Biofarma Ltd

CANF
SABBY MANAGEMENT, LLC's holding in Can Fite Biofarma Ltd over time
0%0.00
$0.00
0%
decreased 100 percentsold off
CPOP
Pop Culture Group Co Ltd

Pop Culture Group Co Ltd

CPOP
SABBY MANAGEMENT, LLC's holding in Pop Culture Group Co Ltd over time
0%0.00
$0.00
0%
decreased 100 percentsold off
FAMI
Farmmi Inc

Farmmi Inc

FAMI
SABBY MANAGEMENT, LLC's holding in Farmmi Inc over time
0.76%3,515,930
$840.3K
0.76%
new position
FLAG
Calidi Biotherapeutics Inc

Calidi Biotherapeutics Inc

FLAG
SABBY MANAGEMENT, LLC's holding in Calidi Biotherapeutics Inc over time
0%0.00
$0.00
0%
decreased 100 percentsold off
MTP
Biodexa Pharmaceuticals Plc

Biodexa Pharmaceuticals Plc

MTP
SABBY MANAGEMENT, LLC's holding in Biodexa Pharmaceuticals Plc over time
0%0.00
$0.00
0%
decreased 100 percentsold off
PRTG
Alphaton Capital Corp

Alphaton Capital Corp

PRTG
SABBY MANAGEMENT, LLC's holding in Alphaton Capital Corp over time
0%0.00
$0.00
0%
decreased 100 percentsold off